What is Sinopharm Group Co Price-to-Operating-Cash-Flow?
As of today (2025-06-27), Sinopharm Group Co's share price is HK$18.64.
Sinopharm Group Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$3.83. Hence, Sinopharm Group Co's Price-to-Operating-Cash-Flow Ratio for today is 4.86.
The historical rank and industry rank for Sinopharm Group Co's Price-to-Operating-Cash-Flow or its related term are showing as below:
HKSE:01099'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.27 Med: 5.09 Max: 33.97
Current: 4.86
During the past 13 years, Sinopharm Group Co's highest Price-to-Operating-Cash-Flow Ratio was 33.97. The lowest was 2.27. And the median was 5.09.
Sinopharm Group Co's Cash Flow from Operations per share for the
six
months ended in Dec. 2024 was HK$17.98.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$3.83.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Sinopharm Group Co was -34.40% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 2.50% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -3.20% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 6.90% per year.
During the past 13 years, Sinopharm Group Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 72.00% per year. The lowest was -37.90% per year. And the median was 22.60% per year.
Sinopharm Group Co Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Sinopharm Group Co's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinopharm Group Co Price-to-Operating-Cash-Flow Chart
|
Sinopharm Group Co Annual Data
|
|
Trend |
Dec15 |
Dec16 |
Dec17 |
Dec18 |
Dec19 |
Dec20 |
Dec21 |
Dec22 |
Dec23 |
Dec24 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
4.43 |
4.63 |
2.64 |
3.40 |
5.43 |
|
Sinopharm Group Co Semi-Annual Data
|
|
Jun15 |
Dec15 |
Jun16 |
Dec16 |
Jun17 |
Dec17 |
Jun18 |
Dec18 |
Jun19 |
Dec19 |
Jun20 |
Dec20 |
Jun21 |
Dec21 |
Jun22 |
Dec22 |
Jun23 |
Dec23 |
Jun24 |
Dec24 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
2.64 |
- |
3.40 |
- |
5.43 |
Competitive Comparison of Sinopharm Group Co's Price-to-Operating-Cash-Flow
For the Medical Distribution subindustry, Sinopharm Group Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinopharm Group Co's Price-to-Operating-Cash-Flow Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Sinopharm Group Co's Price-to-Operating-Cash-Flow falls into.
Sinopharm Group Co Price-to-Operating-Cash-Flow Calculation
Sinopharm Group Co's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 18.64 | / | 3.834 |
| = | 4.86 |
Sinopharm Group Co's Share Price of today is HK$18.64.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sinopharm Group Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$3.83.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Sinopharm Group Co Business Description
Traded in Other Exchanges
Address
No. 385, East Longhua Road, Sinopharm Group Building, Huangpu District, Shanghai, CHN, 200023
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2024. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.
Executives
Sinopharm Group Co Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:01099 has been successfully added to your